Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review

Date: September 27, 2016
Pages: 33
Price:
US$ 300.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C83F3301F2CEN
Leaflet:

Download PDF Leaflet

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review
Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – GlobalData’s summarization of the company’s business strategy.
  • SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights

Chiesi Farmaceutici SpA (Chiesi) researches, develops, distributes and commercializes novel pharmaceutical products with focus on respiratory, cardiology, neonatology, and rare diseases. The company provides products for the treatment of chronic obstructive pulmonary disease COPD, asthma, rheumatoid arthritis, ankylosing spondylitis, osteoarthritis, cardiovascular diseases, apnoea of prematurity, respiratory distress syndrome (RDS), lipoprotein lipase deficiency (LPLD), limbal stem cell deficiency (LSCD), chronic alpha-mannosidosis, inflammatory bowel diseases and renal and liver failure - solid organ transplant (SOT). It also carries out research and development activities at its Parma research center in Italy and in laboratories in Paris, France; Rockville, the US; and Chippenham, the UK. Operating through subsidiaries, Chiesi markets its products across several countries in Europe, Americas and Asia-Pacific. Chiesi is headquartered in Parma, Italy.

Chiesi Farmaceutici SpA Key Recent Developments

Mar 30, 2016: 80 Years of Innovation and Success in Healthcare: Chiesi Reports Significant International Growth in 2015

Reasons to Buy
  • Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
  • Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
  • Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
  • Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
SECTION 1 - ABOUT THE COMPANY

Chiesi Farmaceutici SpA - Key Facts
Chiesi Farmaceutici SpA - Key Employees
Chiesi Farmaceutici SpA - Key Operational Employees
Chiesi Farmaceutici SpA - Major Products and Services
Chiesi Farmaceutici SpA - Pharmaceutical Pipeline Products Data
Chiesi Farmaceutici SpA, Pipeline Products by Therapy Area
Chiesi Farmaceutici SpA, Pipeline Products by Development Phase
Chiesi Farmaceutici SpA - History
Chiesi Farmaceutici SpA - Company Statement
Chiesi Farmaceutici SpA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Chiesi Farmaceutici SpA - Business Description
Chiesi Farmaceutici SpA - Corporate Strategy
Chiesi Farmaceutici SpA - SWOT Analysis
SWOT Analysis - Overview
Chiesi Farmaceutici SpA - Strengths
Strength - Lead Product – Foster
Strength - Emphasis on Research and Development Activities
Strength - Robust Manufacturing Capabilities
Chiesi Farmaceutici SpA - Weaknesses
Weakness - Declining Domestic Revenue
Chiesi Farmaceutici SpA - Opportunities
Opportunity - Strong Product Pipeline
Opportunity - Market Prospects – CVD and Asthma
Opportunity - Strategic Acquisitions
Opportunity - Strategic Partnerships
Chiesi Farmaceutici SpA - Threats
Threat - Failure of New Product in Clinical Trials
Threat - Stringent Government Regulations
Threat - Supply Chain
Chiesi Farmaceutici SpA - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Chiesi Farmaceutici SpA, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Mar 30, 2016: 80 Years of Innovation and Success in Healthcare: Chiesi Reports Significant International Growth in 2015

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Chiesi Farmaceutici SpA, Key Facts
Chiesi Farmaceutici SpA, Key Employees
Chiesi Farmaceutici SpA, Key Operational Employees
Chiesi Farmaceutici SpA, Major Products and Services
Chiesi Farmaceutici SpA, Number of Pipeline Products by Therapy Area
Chiesi Farmaceutici SpA, Number of Pipeline Products by Development Stage
Chiesi Farmaceutici SpA, Pipeline Products By Therapy Area and Development Phase
Chiesi Farmaceutici SpA, History
Chiesi Farmaceutici SpA, Subsidiaries
Chiesi Farmaceutici SpA, Key Competitors
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Type, 2010 to YTD 2016
Chiesi Farmaceutici SpA, Recent Deals Summary

LIST OF FIGURES

Chiesi Farmaceutici SpA, Pipeline Products by Therapy Area
Chiesi Farmaceutici SpA, Pipeline Products by Development Phase
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals By Year, 2010 to YTD 2016
Chiesi Farmaceutici SpA, Pharmaceuticals & Healthcare, Deals by Type, 2010 to YTD 2016

COMPANIES MENTIONED

Zambon Italia S.r.l.
SIFI S.p.A
Siena Biotech S.p.A.
Newron Pharmaceuticals S.p.A.
FB Health S.p.A.
Cosmo Pharmaceuticals NV
Skip to top


Sorgenia SpA - Strategic SWOT Analysis Review US$ 125.00 Nov, 2015 · 28 pages
Sonatrach SPA - Strategic SWOT Analysis Review US$ 300.00 Mar, 2016 · 41 pages
Sonelgaz Spa - Strategic SWOT Analysis Review US$ 125.00 Mar, 2014 · 19 pages
Polynt SpA - Strategic SWOT Analysis Review US$ 125.00 Sep, 2016 · 21 pages

Ask Your Question

Chiesi Farmaceutici SpA - Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: